LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Global Lab Automation Market to Reach USD 5.20 Billion by 2022

By LabMedica International staff writers
Posted on 28 Nov 2017
Print article
The global lab automation market is expected to grow at a CAGR of 5.1% from USD 4.06 billion in 2017 to USD 5.20 billion by 2022, driven by process miniaturization, high demand in drug discovery and clinical diagnostics, higher reproducibility and accuracy, and a large workforce demand and supply gap. Additionally, enhanced productivity and reduced costs, better personnel safety, and small volumes of samples and reagents offered by lab automation are expected to further aid the market growth. However, the high cost of lab automation is limiting its adoption among small and medium-sized labs, which is expected to restrict the market growth.

These are the latest findings of MarketsandMarkets (Northbrook, IL, USA), a global market research company.

On the basis of equipment and software, the software segment is expected to witness the highest growth in the lab automation market during the forecast period, led by the increasing need for efficient data storage, analysis, and sharing methods. Based on application, the genomics solutions segment is expected to register the highest CAGR in the lab automation market during the forecast period, driven by the growing need for high-throughput genomics in research labs, increase in genetic testing in diagnostic labs, and better accuracy and reproducibility.

On the basis of region, North America is expected to command the largest share of the global lab automation market in 2017, while Asia-Pacific is expected to register the highest CAGR during the forecast period. The growth of the Asia-Pacific lab automation market will be driven by the region’s growing economy, increasing healthcare investments leading to increased research activities and adoption of automated systems in clinical diagnostics and drug discovery, large population pool, improving public health awareness, and rising demand for standardization and accreditation in laboratory practices. The ongoing trends in the global lab automation market include process automation, miniaturization, incorporation of robotics in lab automation workflows and expansion of product distribution networks in the Asia-Pacific region.

Related Links:
MarketsandMarkets

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
New
Gold Member
TORCH Panel Rapid Test
Rapid TORCH Panel Test

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: The AI predictive model identifies the most potent cancer killing immune cells for use in immunotherapies (Photo courtesy of Shutterstock)

AI Predicts Tumor-Killing Cells with High Accuracy

Cellular immunotherapy involves extracting immune cells from a patient's tumor, potentially enhancing their cancer-fighting capabilities through engineering, and then expanding and reintroducing them into the body.... Read more

Microbiology

view channel
Image: The T-SPOT.TB test is now paired with the Auto-Pure 2400 liquid handling platform for accurate TB testing (Photo courtesy of Shutterstock)

Integrated Solution Ushers New Era of Automated Tuberculosis Testing

Tuberculosis (TB) is responsible for 1.3 million deaths every year, positioning it as one of the top killers globally due to a single infectious agent. In 2022, around 10.6 million people were diagnosed... Read more